Yüklüyor......
Genetic methylation and lymphoid malignancies: biomarkers of tumor progression and targeted therapy
Lymphoid malignancies, mainly including lymphocytic leukemia and lymphoma, are a group of heterogeneous diseases. Although the clinical outcome of patients has been significantly improved with current immuno-chemotherapy, definitive biomarkers remain to be investigated, particularly those reflecting...
Kaydedildi:
| Asıl Yazarlar: | , , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2013
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4101819/ https://ncbi.nlm.nih.gov/pubmed/24252620 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2050-7771-1-24 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|